Related Experiment Video
Updated: May 17, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Multisteric TRPV1 nocisensor: a target for analgesics
János Szolcsányi1, Zoltán Sándor
1Department of Pharmacology and Pharmacotherapy, University of Pécs Medical School, Hungary. szolcsanyi@aok.pte.hu
Abstract:
Cloning of the transient receptor potential vanilloid type 1 (TRPV1), the heat-gated cation channel/capsaicin receptor expressed by sensory neurons, has opened the door for development of new types of analgesics that selectively act on nociceptors. Here we summarize mutagenetic evidence for selective loss of responsiveness to vanilloids, protons, and heat stimuli to provide clues for avoiding on-target side effects of hyperthermia and burn risk. It is suggested that the complex chemoceptive thermosensor function of TRPV1 (which is modulated by depolarizing stimuli) can be attributed to multisteric gating functions. In this way, it forms the prototype of a new class of ion channels different from the canonical voltage-gated and ligand-gated ones. Several endogenous lipid ligands activate and inhibit TRPV1 and its gating initiates sensory transducer and mediator-releasing functions. Second generation TRPV1 antagonists that do not induce hyperthermia are under development, and a dermal capsaicin patch is already on the market for long-term treatment of neuropathic pain.
Insights
Researchers explored the transient receptor potential vanilloid type 1 (TRPV1) channel, a heat-gated receptor on sensory neurons. Understanding its function aids in developing safer pain relief by avoiding side effects like hyperthermia.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The cloning of the transient receptor potential vanilloid type 1 (TRPV1) channel, a capsaicin receptor on sensory neurons, offers potential for novel analgesic development.
- TRPV1 plays a crucial role as a heat-gated cation channel and chemo-thermosensor.
Purpose of the Study:
- To summarize mutagenetic evidence for selective loss of TRPV1 responsiveness to vanilloids, protons, and heat.
- To provide insights for developing analgesics that avoid on-target side effects such as hyperthermia and burn risk.
Main Methods:
- Review of mutagenetic data to understand TRPV1 channel gating mechanisms.
- Analysis of TRPV1's complex chemoceptive thermosensor function and its modulation by depolarizing stimuli.
Main Results:
- Mutagenetic studies suggest multisteric gating functions underlie TRPV1's thermosensor activity.
- Endogenous lipid ligands modulate TRPV1 activation and inhibition, initiating sensory transduction and mediator release.
- TRPV1 represents a novel class of ion channels distinct from canonical voltage-gated and ligand-gated channels.
Conclusions:
- Understanding TRPV1 gating is key to designing safer analgesics targeting nociceptors.
- Second-generation TRPV1 antagonists are being developed to mitigate hyperthermia side effects.
- A dermal capsaicin patch is available for chronic neuropathic pain management.
Related Concept Videos
Thermosensation
Analgesia and Pain Management
Nociception
Local Anesthetics: Differential Sensitivity of Nerve Fibers
